<!-- #BeginTemplate "/Templates/new news.dwt" -->
<head>
<!-- #BeginEditable "doctitle" -->
<TITLE> Rep. Henry A. Waxman</TITLE>
<!-- #EndEditable -->
</head>

<table width="100%" border="0">
<tr>
<!-- #BeginEditable "Contact" -->        
<td align="left" valign="top" width="200"><p><font size="2" face="Arial, Helvetica, sans-serif"><b>FOR IMMEDIATE RELEASE</b><br>
JUNE 9, 2005<br>  
   10:29 AM<br> </font></p></td><td align="left" valign="top" width="330"><p><font face="Arial, Helvetica, sans-serif" size="2"><b>CONTACT</b>:  <b><a href="http://www.house.gov/waxman/" target="_new">Rep. Henry A. Waxman<br></a>     </b>Karen Lightfoot, (202) 225-5051<br></font></p></td><!-- #EndEditable -->
</tr>
<tr>
<td colspan="2">&nbsp;</td></tr>

<tr>
<td colspan="2">
<font size="4" face="Arial, Helvetica, sans-serif"><b>
<!-- #BeginEditable "Header" --><div align="center">CAFTA Hinders Developing Nations' Access to Needed Medicines </div><!-- #EndEditable -->
</b></font>
</td></tr>
<tr>
<td colspan="2">&nbsp;</td></tr>
<tr>
<td colspan="2">
<!-- #BeginEditable "Body" -->
<p><font face="Arial, Helvetica, sans-serif" size="2">WASHINGTON - June 9 - Today Rep. Henry A. Waxman released a new report detailing how CAFTA and other Bush Administration trade agreements are impeding the rights of developing nations to acquire essential medicines at affordable prices.</font></p>
<p><font face="Arial, Helvetica, sans-serif" size="2">&quot;The trade agreements have multiple provisions that block developing nations from getting timely access to lifesaving drugs,&quot; said Rep. Waxman.  &quot;The health implications of the trade agreements for the developing world are serious.&quot;</font></p>
<p><font face="Arial, Helvetica, sans-serif" size="2">The report, prepared for Rep. Waxman by the minority staff of the Committee on Government Reform, describes how CAFTA and six other trade agreements signed or under negotiation by the Bush Administration compromise the principles adopted in the 2001 Doha Declaration, an international agreement that trade accords should not interfere with public health and access to medicines.</font></p>
<p><font face="Arial, Helvetica, sans-serif" size="2">Specifically, the Bush Administration trade agreements:</font></p><p> </p><ul>
 <li><font face="Arial, Helvetica, sans-serif" size="2">Delay approval of affordable generic drugs.  Under the agreements, developing nations cannot acquire low-cost generic drugs unless they have first given the maker of the brand-name drug five years of market exclusivity.</font></li>
 <li><font face="Arial, Helvetica, sans-serif" size="2">Require patent extensions.  Provisions in the agreements require developing nations to give brand-name drug companies patent extensions to compensate for delays in regulatory approval processes.</font></li>
 <li><font face="Arial, Helvetica, sans-serif" size="2">Restrict compulsory licensing.  Several of the agreements limit the conditions under which developing nations can authorize generic manufacturers to make inexpensive versions of patented drugs, even though this right to issue &quot;compulsory licenses&quot; is expressly recognized in the Doha Declaration.</font></li>
 <li><font face="Arial, Helvetica, sans-serif" size="2">Block parallel importation.  Contrary to the Doha Declaration, some of the agreements strip developing nations of their rights to import patented drugs from abroad at the lowest available prices.  </font></li>
</ul>
<p><font face="Arial, Helvetica, sans-serif" size="2">The full report is available at <a href="http://www.democrats.reform.house.gov" target="_new">www.democrats.reform.house.gov</a>. </font></p><p align="CENTER"><font size="2" face="Arial, Helvetica, sans-serif" color="#000000">###</font><!-- #EndEditable -->
</td></tr>
</table>
<!-- #EndTemplate -->
